 |
3 Diseases |  |
0 Trials |
|
0 Trials |  |
10 News |  |
- |||| 514G3 / XBiotech
Trial completion: A Study of the Safety and Efficacy of 514G3 in Subjects Hospitalized With Bacteremia Due to Staphylococcus Aureus (clinicaltrials.gov) - Feb 17, 2017
P1/2, N=52, Completed, Sponsor: XBiotech, Inc.
Active, not recruiting --> Completed
- ||| 514G3 / XBiotech
Enrollment closed, Trial primary completion date: A Study of the Safety and Efficacy of 514G3 in Subjects Hospitalized With Bacteremia Due to Staphylococcus Aureus (clinicaltrials.gov) - Dec 23, 2016
P1/2, N=52, Active, not recruiting, Sponsor: XBiotech, Inc.
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2016 --> Jan 2017
- || 514G3 / XBiotech
Trial primary completion date: A Study of the Safety and Efficacy of 514G3 in Subjects Hospitalized With Bacteremia Due to Staphylococcus Aureus (clinicaltrials.gov) - Mar 28, 2016
P1/2, N=52, Recruiting, Sponsor: XBiotech, Inc.
Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2016 --> Jan 2017 Trial primary completion date: Jan 2016 --> Jun 2016
- |||| 514G3 / XBiotech
Enrollment open, Trial primary completion date: A Study of the Safety and Efficacy of 514G3 in Subjects Hospitalized With Bacteremia Due to Staphylococcus Aureus (clinicaltrials.gov) - Jun 15, 2015
P1/2, N=52, Recruiting, Sponsor: XBiotech, Inc.
Trial primary completion date: Jan 2016 --> Jun 2016 Not yet recruiting --> Recruiting | Trial primary completion date: Oct 2015 --> Jan 2016
- ||||| 514G3 / XBiotech
New P1/2 trial: A Study of the Safety and Efficacy of 514G3 in Subjects Hospitalized With Bacteremia Due to Staphylococcus Aureus (clinicaltrials.gov) - Feb 6, 2015
P1/2, N=52, Not yet recruiting, Sponsor: XBiotech, Inc.